MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals
- PMID: 16886064
- PMCID: PMC1523415
- DOI: 10.1172/JCI28075
MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals
Abstract
While it is known that monosodium urate (MSU) crystals cause the disease gout, the mechanism by which these crystals stimulate this inflammatory condition has not been clear. Here we find that the Toll/IL-1R (TIR) signal transduction adaptor myeloid differentiation primary response protein 88 (MyD88) is required for acute gouty inflammation. In contrast, other TIR adaptor molecules, TIRAP/Mal, TRIF, and TRAM, are not required for this process. The MyD88-dependent TLR1, -2, -4, -6, -7, -9, and -11 and IL-18 receptor (IL-18R) are not essential for MSU-induced inflammation. Moreover, MSU does not stimulate HEK cells expressing TLR1-11 to activate NF-kappaB. In contrast, mice deficient in the MyD88-dependent IL-1R showed reduced inflammatory responses, similar to those observed in MyD88-deficient mice. Similarly, mice treated with IL-1 neutralizing antibodies also showed reduced MSU-induced inflammation, demonstrating that IL-1 production and IL-1R activation play essential roles in MSU-triggered inflammation. IL-1R deficiency in bone marrow-derived cells did not affect the inflammatory response; however, it was required in non-bone marrow-derived cells. These results indicate that IL-1 is essential for the MSU-induced inflammatory response and that the requirement of MyD88 in this process is primarily through its function as an adaptor molecule in the IL-1R signaling pathway.
Figures









Comment in
-
Gout: new insights into an old disease.J Clin Invest. 2006 Aug;116(8):2073-5. doi: 10.1172/JCI29404. J Clin Invest. 2006. PMID: 16886051 Free PMC article.
Similar articles
-
Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation.Arthritis Rheum. 2005 Sep;52(9):2936-46. doi: 10.1002/art.21238. Arthritis Rheum. 2005. PMID: 16142712
-
Gout: new insights into an old disease.J Clin Invest. 2006 Aug;116(8):2073-5. doi: 10.1172/JCI29404. J Clin Invest. 2006. PMID: 16886051 Free PMC article.
-
A unique feature of Toll/IL-1 receptor domain-containing adaptor protein is partially responsible for lipopolysaccharide insensitivity in zebrafish with a highly conserved function of MyD88.J Immunol. 2010 Sep 15;185(6):3391-400. doi: 10.4049/jimmunol.0903147. Epub 2010 Aug 11. J Immunol. 2010. PMID: 20702732
-
[Pathological mechanisms of gouty arthritis].Nihon Rinsho. 2008 Apr;66(4):705-10. Nihon Rinsho. 2008. PMID: 18409519 Review. Japanese.
-
Toll/interleukin-1 receptor (TIR) domain-mediated cellular signaling pathways.Apoptosis. 2015 Feb;20(2):196-209. doi: 10.1007/s10495-014-1073-1. Apoptosis. 2015. PMID: 25563856 Review.
Cited by
-
NLRP3 tyrosine phosphorylation is controlled by protein tyrosine phosphatase PTPN22.J Clin Invest. 2016 May 2;126(5):1783-800. doi: 10.1172/JCI83669. Epub 2016 Apr 4. J Clin Invest. 2016. PMID: 27043286 Free PMC article.
-
Cell death in chronic inflammation: breaking the cycle to treat rheumatic disease.Nat Rev Rheumatol. 2020 Sep;16(9):496-513. doi: 10.1038/s41584-020-0455-8. Epub 2020 Jul 8. Nat Rev Rheumatol. 2020. PMID: 32641743 Review.
-
Enhanced interleukin-1β production of PBMCs from patients with gout after stimulation with Toll-like receptor-2 ligands and urate crystals.Arthritis Res Ther. 2012 Jul 4;14(4):R158. doi: 10.1186/ar3898. Arthritis Res Ther. 2012. PMID: 22762240 Free PMC article.
-
Recent developments in crystal-induced inflammation pathogenesis and management.Curr Rheumatol Rep. 2007 Jun;9(3):243-50. doi: 10.1007/s11926-007-0039-5. Curr Rheumatol Rep. 2007. PMID: 17531179 Review.
-
Urate-induced immune programming: Consequences for gouty arthritis and hyperuricemia.Immunol Rev. 2020 Mar;294(1):92-105. doi: 10.1111/imr.12833. Epub 2019 Dec 19. Immunol Rev. 2020. PMID: 31853991 Free PMC article. Review.
References
-
- Terkeltaub, R. 2005. Pathogenesis and treatment of crystal-induced inflammation. InArthritis and allied conditions. W. Koopman and L.W. Moreland, editors. Lippincott Williams & Wilkins. Philadelphia, Pennsylvania, USA. 2357.
-
- [Anonymous]. . Carl Wilhelm Scheele (1742-1786) Swedish apothecary. Jama. 1970;212:2258–2259. - PubMed
-
- Freudweiler M. Studies on the nature of gouty tophi. Dtsch. Arch. Klin. Med. 1899;63:266.
-
- Rich A.M., Giedd K.N., Cristello P., Weissmann G. Granules are necessary for death of neutrophils after phagocytosis of crystalline monosodium urate. Inflammation. 1985;9:221–232. - PubMed
-
- Tramontini N., Huber C., Liu-Bryan R., Terkeltaub R.A., Kilgore K.S. Central role of complement membrane attack complex in monosodium urate crystal-induced neutrophilic rabbit knee synovitis. Arthritis Rheum. 2004;50:2633–2639. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous